A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain-Reference-Cited by-同舟云学术

A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain

Published:2010-02 Issue:1-3 Volume:628 Page:83-90
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Popa Daniela,Cerdan Julie,Repérant Christelle,Guiard Bruno P.,Guilloux Jean-Philippe,David Denis J.,Gardier Alain M.

Funder

Fondation pour la Recherche Médicale

Université Paris-Sud

Publisher

Elsevier BV

Subject

Pharmacology

Reference59 articles.

1. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter;Alexandre;J. Neurosci.,2006

2. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors;Artigas;Arch. Gen. Psychiatry,1994

3. Pindolol augmentation of antidepressant response;Artigas;Curr. Drug Targets,2006

4. A PET imaging study of 5-HT, 1A. Receptors in cat brain after acute and chronic fluoxetine treatment;Aznavour;Neuroimage,2006

5. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects;Barr;Biol. Psychiatry,1997

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice;Nature Communications;2024-07-31

2. The Antidepressant Action of Fluoxetine Involves the Inhibition of Dlx5/6 in Cortical GABAergic Neurons through a TrkB-Dependent Pathway;Cells;2024-07-26

3. TrkB-dependent antidepressants action involves Dlx5/6 inhibition in cortical GABAergic neurons.;2024-06-07

4. A review of the pharmacological action and mechanism of natural plant polysaccharides in depression;Frontiers in Pharmacology;2024-02-08

5. Duloxetine improves chronic orofacial pain and comorbid depressive symptoms in association with reduction of serotonin transporter protein through upregulation of ubiquitinated serotonin transporter protein;Pain;2024-01-11